Simon J. Gunter

Economics, Econometrics and FinanceMedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020”.

Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.12454

N/A

0DataRank · unranked

28 citations

Simon J. Gunter, Aaron S. Kesselheim, Beatrice L. Brown, Krysten W. Joyce, Murray N. Ross +4 more

Cost of care associated with utilization of telehealth in clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13682

N/A

0DataRank · unranked

2 citations

Elizabeth Tubridy, Leslie Andriani, Destiny Uwawuike, Simon J. Gunter, Nathanael Koelper +3 more

Cost of care associated with utilization of telehealth in clinical trials

Gynecologic Oncology Reports(2024)10.1016/j.gore.2024.101523

N/A

0DataRank · unranked

0 citations

Leslie Andriani, Elizabeth Tubridy, Destiny Uwawuike, Simon J. Gunter, Nathanael Koelper +3 more